Joanne Wuensch
Stock Analyst at Citigroup
(4.40)
# 338
Out of 5,084 analysts
426
Total ratings
64.91%
Success rate
12.1%
Average return
Main Sectors:
Stocks Rated by Joanne Wuensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ITGR Integer Holdings | Maintains: Neutral | $77 → $69 | $70.62 | -2.29% | 8 | Nov 3, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Sell | $12 → $11 | $13.55 | -18.84% | 16 | Oct 31, 2025 | |
| BAX Baxter International | Maintains: Neutral | $26 → $21 | $18.48 | +13.64% | 22 | Oct 31, 2025 | |
| IRTC iRhythm Technologies | Maintains: Buy | $205 → $242 | $181.60 | +33.26% | 22 | Oct 31, 2025 | |
| EW Edwards Lifesciences | Maintains: Buy | $95 → $96 | $85.78 | +11.91% | 21 | Oct 31, 2025 | |
| DXCM DexCom | Maintains: Buy | $85 → $75 | $65.27 | +14.91% | 16 | Oct 31, 2025 | |
| GKOS Glaukos | Maintains: Buy | $110 → $113 | $108.85 | +3.81% | 22 | Oct 30, 2025 | |
| JNJ Johnson & Johnson | Maintains: Buy | $213 → $215 | $202.48 | +6.18% | 15 | Oct 15, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Neutral | $11 → $15 | $20.65 | -27.36% | 20 | Oct 7, 2025 | |
| SGHT Sight Sciences | Maintains: Neutral | $4.5 → $4 | $8.35 | -52.10% | 13 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $101 → $112 | $101.99 | +9.81% | 22 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $64 | $83.81 | -23.64% | 9 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $93 → $83 | $82.46 | +0.66% | 7 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $97 → $72 | $77.30 | -6.86% | 21 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $157 → $155 | $125.40 | +23.60% | 22 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $320 → $285 | $294.72 | -3.30% | 25 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $47 | $71.01 | -33.81% | 7 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $16.81 | -10.77% | 6 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $443 → $455 | $364.35 | +24.88% | 14 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6.5 → $4.15 | $2.14 | +94.38% | 12 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $590 → $650 | $568.65 | +14.31% | 17 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $380 | $316.45 | +20.08% | 16 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $119 → $125 | $97.72 | +27.92% | 35 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $134 → $120 | $93.16 | +28.81% | 22 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $220 → $250 | $193.76 | +29.03% | 5 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $67 → $69 | $78.99 | -12.65% | 5 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $109 → $127 | $251.51 | -49.50% | 6 | Dec 10, 2018 |
Integer Holdings
Nov 3, 2025
Maintains: Neutral
Price Target: $77 → $69
Current: $70.62
Upside: -2.29%
Integra LifeSciences Holdings
Oct 31, 2025
Maintains: Sell
Price Target: $12 → $11
Current: $13.55
Upside: -18.84%
Baxter International
Oct 31, 2025
Maintains: Neutral
Price Target: $26 → $21
Current: $18.48
Upside: +13.64%
iRhythm Technologies
Oct 31, 2025
Maintains: Buy
Price Target: $205 → $242
Current: $181.60
Upside: +33.26%
Edwards Lifesciences
Oct 31, 2025
Maintains: Buy
Price Target: $95 → $96
Current: $85.78
Upside: +11.91%
DexCom
Oct 31, 2025
Maintains: Buy
Price Target: $85 → $75
Current: $65.27
Upside: +14.91%
Glaukos
Oct 30, 2025
Maintains: Buy
Price Target: $110 → $113
Current: $108.85
Upside: +3.81%
Johnson & Johnson
Oct 15, 2025
Maintains: Buy
Price Target: $213 → $215
Current: $202.48
Upside: +6.18%
Tandem Diabetes Care
Oct 7, 2025
Maintains: Neutral
Price Target: $11 → $15
Current: $20.65
Upside: -27.36%
Sight Sciences
Oct 7, 2025
Maintains: Neutral
Price Target: $4.5 → $4
Current: $8.35
Upside: -52.10%
Oct 7, 2025
Maintains: Buy
Price Target: $101 → $112
Current: $101.99
Upside: +9.81%
Oct 7, 2025
Maintains: Buy
Price Target: $78 → $64
Current: $83.81
Upside: -23.64%
Oct 7, 2025
Downgrades: Neutral
Price Target: $93 → $83
Current: $82.46
Upside: +0.66%
Aug 28, 2025
Downgrades: Neutral
Price Target: $97 → $72
Current: $77.30
Upside: -6.86%
Jul 18, 2025
Maintains: Buy
Price Target: $157 → $155
Current: $125.40
Upside: +23.60%
Jul 9, 2025
Maintains: Neutral
Price Target: $320 → $285
Current: $294.72
Upside: -3.30%
Jul 9, 2025
Maintains: Neutral
Price Target: $38 → $47
Current: $71.01
Upside: -33.81%
Jul 9, 2025
Maintains: Neutral
Price Target: $13 → $15
Current: $16.81
Upside: -10.77%
May 22, 2025
Maintains: Buy
Price Target: $443 → $455
Current: $364.35
Upside: +24.88%
May 22, 2025
Maintains: Neutral
Price Target: $6.5 → $4.15
Current: $2.14
Upside: +94.38%
May 22, 2025
Maintains: Buy
Price Target: $590 → $650
Current: $568.65
Upside: +14.31%
May 22, 2025
Maintains: Buy
Price Target: $320 → $380
Current: $316.45
Upside: +20.08%
May 22, 2025
Maintains: Buy
Price Target: $119 → $125
Current: $97.72
Upside: +27.92%
Jul 10, 2024
Maintains: Neutral
Price Target: $134 → $120
Current: $93.16
Upside: +28.81%
Dec 12, 2022
Upgrades: Neutral
Price Target: $220 → $250
Current: $193.76
Upside: +29.03%
Nov 17, 2022
Maintains: Neutral
Price Target: $67 → $69
Current: $78.99
Upside: -12.65%
Dec 10, 2018
Upgrades: Outperform
Price Target: $109 → $127
Current: $251.51
Upside: -49.50%